| Literature DB >> 30065663 |
Marianna Meo1,2,3, Thomas Pambrun1,4, Nicolas Derval1,4, Carole Dumas-Pomier5, Stéphane Puyo1,4, Josselin Duchâteau1,2,3,4, Pierre Jaïs1,2,3,4, Mélèze Hocini1,2,3,4, Michel Haïssaguerre1,2,3,4, Rémi Dubois1,2,3.
Abstract
Background: The use of surface recordings to assess atrial fibrillation (AF) complexity is still limited in clinical practice. We propose a noninvasive tool to quantify AF complexity from body surface potential maps (BSPMs) that could be used to choose patients who are eligible for AF ablation and assess therapy impact.Entities:
Keywords: atrial fibrillation; atrial fibrillation complexity; body surface potential maps; catheter ablation; principal component analysis
Year: 2018 PMID: 30065663 PMCID: PMC6056813 DOI: 10.3389/fphys.2018.00929
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Study population characteristics.
| Sex, male, | 80 (82) |
| Age, mean ± std, years | 64 ± 11 |
| Hypertension, | 42 (42) |
| Diabetes mellitus, | 10 (17) |
| Embolic events, | 8 (8) |
| Structural heart disease, | 61 (62) |
| Ischemic, | 10 (10) |
| Valvular, | 6 (6) |
| Hypertrophic, | 8 (8) |
| Dilated, | 35 (36) |
| Other, | 2 (2) |
| Left ventricular ejection fraction, mean ± std, % | 52 ± 13 |
| LA diameter, parasternal long axis, mm | 48 ± 7 |
| LA Area, mm2 | 26 ± 6 |
| Patients presenting in AF, AF duration, months | 9.6 ± 10.2 |
| < 12 months | 74 (76) |
| ≥ 12 months | 23 (24) |
| Patient presenting in SR, | 48 (49) |
| Patients with more than 1 DCC, | 54 (56) |
| Number of AADs before CA, mean ± std | 2 ± 1 |
| Patients on amiodarone before CA, | 40 (41) |
Baseline characteristics of the AF population; std, standard deviation; DCC, electrical cardioversion; AAD, antiarrhythmic drugs.
Figure 1A representative example of f-wave signal extracted from a BSPM recording in an AF patient (lead 1). Concatenated, preprocessed TQ intervals are separated by dashed, red, vertical lines.
Figure 2Biatrial schematic representation: 1, left pulmonary veins and LAA; 2, right pulmonary veins and posterior interatrial groove; 3, inferior and posterior left atrium; 4, upper half of right atrium and appendage; 5, lower half of right atrium; 6, anterior left atrium and roof; 7, anterior interatrial groove.
Figure 3Noninvasive markers of AF complexity and AF CL: correlation of surface signal features with AF disease chronification based on atrial AF CL. (A) The NDI index measured in BSPMs (NDI, left) and the standard ECG subset (NDIECG, right). (B) Clinical measures of cardiac activity: AF duration (left) and LA area (right). (C) Single-lead descriptors of atrial amplitude (AV1, left), surface CL (CLV1, middle) and PCA estimation error (NMSE3, right) in V1. (D) Multilead PCA reconstruction error (WNMSEBSPM, left) and f-wave amplitude (ABSPM, right) computed in BSPMs and in the standard ECG subset (WNMSEECG and AECG). (E) Multilead PCA reconstruction error (WNMSEOACG, left) and f-wave amplitude (AOACG, right) computed in the modified OACG system and in the extended 15-lead ECG (WNMSEECG15 and AECG15). *p < 0.05 vs. <160 ms; ns, not significant; a.u., arbitrary units.
Figure 4Noninvasive markers of AF complexity and continuous AF duration: correlation of surface signal features with AF disease chronification based on the duration of the last continuous episode. (A) The NDI index measured in BSPMs (NDI, left) and the standard ECG subset (NDIECG, right). (B) Single-lead descriptors of atrial amplitude (AV1, left), surface CL (CLV1, middle) and PCA estimation error (NMSE3, right) in V1. (C) Multilead PCA reconstruction error (WNMSEBSPM, left) and f-wave amplitude (ABSPM, right) computed in BSPMs and in the standard ECG subset (WNMSEECG and AECG). (D) Multilead PCA reconstruction error (WNMSEOACG, left) and f-wave amplitude (AOACG, right) computed in the modified OACG system and in the extended 15-lead ECG (WNMSEECG15 and AECG15). *p < 0.05 vs. persistent AF; ns, not significant; a.u., arbitrary units.
ROC analysis of the AF complexity features and AF duration.
| NDI [a.u] | |||
| LA area [cm2] | 59 | 36 | 79 |
| AV1 [mV] | 52 | 55 | 60 |
| CLV1 [ms] | 60 | 45 | 82 |
| NMSE3 [%] | 51 | 55 | 60 |
| WNMSEBSPM [%] | 58 | 86 | 42 |
| ABSPM [mV] | 59 | 91 | 30 |
| NDIECG [a.u] | 63 | 58 | 84 |
| WNMSEECG [%] | 58 | 55 | 68 |
| AECG [mV] | 54 | 58 | 64 |
| NDIOACG [a.u] | 59 | 37 | 90 |
| WNMSEOACG [%] | 57 | 47 | 69 |
| AOACG [mV] | 58 | 79 | 48 |
| NDIECG15 [a.u] | 65 | 63 | 76 |
| WNMSEECG15 [%] | 56 | 95 | 24 |
| AECG15 [mV] | 61 | 42 | 85 |
Assessment of the ability of the AF organization markers to discriminate between persistent and long-lasting AF patients. Sensitivity and specificity indicate the rate of correct detections in the long-lasting and persistent AF patients' groups, respectively. Results for the parameters with the highest classification performance (AUC≥70%) are highlighted in boldface. AUC, area under curve; a.u., arbitrary units.
Noninvasive markers of AF complexity and ablation time.
| NDI [a.u] | 0.086 ± 0.036 | 0.107 ± 0.032 | |
| AF duration [months] | 5.9 ± 6.0 | 9.2 ± 8.7 | |
| LA area [cm2] | 26 ± 6 | 26 ± 7 | 0.65 |
| AV1 [mV] | 0.022 ± 0.015 | 0.032 ± 0.023 | 0.063 |
| CLV1 [ms] | 168 ± 34 | 145 ± 32 | |
| NMSE3 [%] | 23.4 ± 17.7 | 25.2 ± 19.4 | 0.71 |
| WNMSEBSPM [%] | 42.4 ± 26.0 | 53.8 ± 26.3 | 0.064 |
| ABSPM [mV] | 0.013 ± 0.006 | 0.012 ± 0.005 | 0.81 |
| NDIECG [a.u] | 0.047 ± 0.016 | 0.055 ± 0.023 | 0.26 |
| WNMSEECG [%] | 42.4 ± 25.3 | 46.8 ± 24.0 | 0.49 |
| AECG [mV] | 0.010 ± 0.006 | 0.015 ± 0.008 | |
| NDIOACG [a.u] | 0.051 ± 0.022 | 0.060 ± 0.025 | 0.15 |
| WNMSEOACG [%] | 49.6 ± 27.6 | 48.0 ± 25.5 | 0.72 |
| AOACG [mV] | 0.010 ± 0.0006 | 0.013 ± 0.007 | 0.11 |
| NDIECG15 [a.u] | 0.058 ± 0.019 | 0.071 ± 0.029 | |
| WNMSEECG15 [%] | 55.6 ± 25.0 | 55.3 ± 26.6 | 0.80 |
| AECG15 [mV] | 0.009 ± 0.004 | 0.013 ± 0.007 |
Correlation of body surface signal features with the duration of radiofrequency emission duration to achieve procedural AF termination; p values in boldface are statistically significant; a.u., arbitrary units.
ROC analysis of the AF complexity features and ablation time.
| NDI [a.u] | |||
| AF duration [months] | 64 | 28 | 97 |
| LA area [cm2] | 53 | 51 | 66 |
| AV1 [mV] | 64 | 61 | 73 |
| CLV1 [ms] | |||
| NMSE3 [%] | 53 | 35 | 83 |
| WNMSEBSPM [%] | 63 | 79 | 47 |
| ABSPM [mV] | 52 | 44 | 71 |
| NDIECG [a.u] | 59 | 63 | 61 |
| WNMSEECG [%] | 56 | 48 | 70 |
| AECG [mV] | 68 | 57 | 79 |
| NDIOACG [a.u] | 61 | 43 | 82 |
| WNMSEOACG [%] | 53 | 90 | 29 |
| AOACG [mV] | 61 | 37 | 89 |
| NDIECG15 [a.u] | 65 | 70 | 61 |
| WNMSEECG15 [%] | 52 | 23 | 93 |
| AECG15 [mV] | 67 | 47 | 86 |
Assessment of the ability of the AF organization descriptors to distinguish between short and long AF ablation procedures. Sensitivity and specificity indicate the percentage of interventions correctly identified by the signal features based on the duration of radiofrequency emission duration to AF termination, i.e., longer/shorter than 30 min, respectively. Results for the parameters with the highest classification performance (AUC≥70%) are highlighted in boldface. AUC, area under curve; a.u., arbitrary units.
Noninvasive markers of AF complexity and number of CA targets.
| NDI [a.u] | 0.086 ± 0.030 | 0.111 ± 0.037 | |
| AF duration [months] | 4.6 ± 3.4 | 12.6 ± 13.1 | |
| LA area [cm2] | 27 ± 6 | 26 ± 6 | 0.56 |
| AV1 [mV] | 0.024 ± 0.016 | 0.030 ± 0.024 | 0.27 |
| CLV1 [ms] | 167 ± 35 | 147 ± 29 | |
| NMSE3 [%] | 21.8 ± 18.0 | 24.4 ± 18.5 | 0.54 |
| WNMSEBSPM [%] | 43.3 ± 27.6 | 52.8 ± 24.7 | 0.065 |
| ABSPM [mV] | 0.012 ± 0.006 | 0.011 ± 0.005 | 0.32 |
| NDIECG [a.u] | 0.048 ± 0.019 | 0.055 ± 0.022 | 0.18 |
| WNMSEECG [%] | 39.1 ± 24.9 | 46, 59 ± 23.4 | 0.49 |
| AECG [mV] | 0.011 ± 0.006 | 0.013 ± 0.008 | 0.26 |
| NDIOACG [a.u] | 0.054 ± 0.027 | 0.059 ± 0.022 | 0.18 |
| WNMSEOACG [%] | 46.9 ± 29.1 | 50.8 ± 24.1 | 0.62 |
| AOACG [mV] | 0.012 ± 0.006 | 0.0012 ± 0.007 | 0.71 |
| NDIECG15 [a.u] | 0.059 ± 0.021 | 0.071 ± 0.029 | 0.11 |
| WNMSEECG15 [%] | 51.7 ± 26.2 | 57.4 ± 22.9 | 0.75 |
| AECG15 [mV] | 0.010 ± 0.005 | 0.011 ± 0.006 | 0.63 |
Correlation of BSPM features with the number of atrial sites ablated to achieve procedural AF termination; p values in boldface are statistically significant; a.u., arbitrary units.
ROC analysis of the AF complexity features and number of CA targets.
| NDI [a.u] | 69 | 67 | 71 |
| AF duration [months] | |||
| LA area [cm2] | 54 | 67 | 45 |
| AV1 [mV] | 58 | 54 | 64 |
| CLV1 [ms] | 68 | 85 | 39 |
| NMSE3 [%] | 54 | 35 | 82 |
| WNMSEBSPM [%] | 61 | 88 | 38 |
| ABSPM [mV] | 56 | 23 | 92 |
| NDIECG [a.u] | 59 | 37 | 92 |
| WNMSEECG [%] | 59 | 69 | 50 |
| AECG [mV] | 58 | 80 | 38 |
| NDIOACG [a.u] | 59 | 47 | 77 |
| WNMSEOACG [%] | 53 | 82 | 35 |
| AOACG [mV] | 53 | 86 | 31 |
| NDIECG15 [a.u] | 61 | 37 | 88 |
| WNMSEECG15 [%] | 56 | 74 | 42 |
| AECG15 [mV] | 53 | 92 | 19 |
Assessment of the ability of the AF organization descriptors to identify extensive ablation procedures in terms of the number of atrial sites targeted to achieve AF termination. Sensitivity and specificity indicate the percentage of procedures correctly classified by the signal features based on the number of ablation targets, i.e., more/less than 4 sites, respectively. Results for the parameters with the highest classification performance (AUC≥70%) are highlighted in boldface. AUC, area under curve; a.u., arbitrary units.
Figure 5Noninvasive markers of AF complexity and CA outcome: correlation of BSPM features with the acute CA outcome. (A) The NDI index measured in BSPMs (NDI, left) and the standard ECG subset (NDIECG, right). (B) Clinical measures of cardiac activity: AF duration (left) and LA area (right). (C) Single-lead descriptors of atrial amplitude (AV1, left), surface CL (CLV1, middle) and PCA estimation error (NMSE3, right) in V1. (D) Multilead PCA reconstruction error (WNMSEBSPM, left) and f-wave amplitude (ABSPM, right) computed in BSPMs and in the standard ECG subset (WNMSEECG and AECG). (E) Multilead PCA reconstruction error (WNMSEOACG, left) and f-wave amplitude (AOACG, right) computed in the modified OACG system and in the extended 15-lead ECG (WNMSEECG15 and AECG15). *p < 0.05 vs. AF termination; ns, not significant; a.u., arbitrary units.
ROC analysis of the AF complexity features and CA outcome.
| NDI [a.u] | 69 | 70 | 67 |
| AF duration [months] | |||
| LA area [cm2] | 51 | 65 | 53 |
| AV1 [mV] | 51 | 84 | 33 |
| CLV1 [ms] | 52 | 37 | 75 |
| NMSE3 [%] | 56 | 32 | 85 |
| WNMSEBSPM [%] | 57 | 95 | 26 |
| ABSPM [mV] | 67 | 85 | 40 |
| NDIECG [a.u] | 56 | 37 | 81 |
| WNMSEECG [%] | 53 | 63 | 49 |
| AECG [mV] | 51 | 84 | 33 |
| NDIOACG [a.u] | 57 | 37 | 88 |
| WNMSEOACG [%] | 52 | 63 | 52 |
| AOACG [mV] | 50 | 98 | 24 |
| NDIECG15 [a.u] | 58 | 47 | 85 |
| WNMSEECG15 [%] | 51 | 95 | 26 |
| AECG15 [mV] | 54 | 84 | 33 |
Assessment of the ability of the AF organization descriptors to predict AF termination by CA. Sensitivity and specificity indicate the rate of detection of successful and failed ablation procedures, respectively. Results for the parameters with the highest classification performance (AUC≥70%) are highlighted in boldface. AUC, area under curve; a.u., arbitrary units.
Multivariate classification performance based on ablation duration and NRI assessment.
| NDI [a.u.] | 56 | 42 | 65 | 29 | 100 | 14 | 62 | 45 | 65 | 80 | 57 | −0.04 | 0.89 | |
| AF duration [months] | 41 | 32 | 52 | 49 | 40 | 86 | 53 | 39 | 68 | 29 | 100 | 14 | 0.18 | 0.56 |
| CL V1 [ms] | 59 | 42 | 71 | 29 | 100 | 14 | 61 | 42 | 71 | 100 | 60 | 0.12 | 0.32 | |
| ABSPM [mV] | 54 | 35 | 65 | 29 | 100 | 14 | 54 | 35 | 65 | 100 | 80 | 0.23 | 0.37 | |
| NDIECG15 [a.u] | 57 | 19 | 66 | 43 | 100 | 29 | 63 | 46 | 55 | 100 | 60 | −0.16 | 0.50 | |
| AECG15 [mV] | 57 | 35 | 71 | 29 | 100 | 14 | 61 | 39 | 71 | 100 | 60 | −0.04 | 0.89 | |
ROC analysis of the multivariate classifiers obtained by using clinical data only (F.
Multivariate classification performance based on the number of ablation targets and NRI assessment.
| NDI [a.u.] | 79 | 53 | 64 | 50 | 86 | 47 | 79 | 86 | 83 | 0.24 | 0.28 | |||
| AF duration [months] | 53 | 96 | 7 | 40 | 100 | 17 | 82 | 52 | 52 | 71 | 50 | 0.17 | 0.62 | |
| CLV1 [ms] | 80 | 52 | 52 | 71 | 50 | 86 | 41 | 57 | 100 | −0.04 | 0.81 | |||
ROC analysis of the multivariate classifiers obtained by using clinical data only (F.
Multivariate ablation outcome classification performance and NRI assessment.
| NDI [a.u.] | 58 | 19 | 97 | 67 | 67 | 90 | 60 | 25 | 92 | 100 | 50 | 0 | N.A | |
| AF duration [months] | 19 | 0 | 100 | 43 | 33 | 100 | 56 | 98 | 19 | 67 | 67 | 90 | 0 | N.A |
| ABSPM [mV] | 59 | 15 | 97 | 67 | 67 | 90 | 66 | 15 | 97 | 67 | 100 | 0.25 | 0.32 | |
ROC analysis of the multivariate predictors of ablation outcome obtained by using clinical data only (F.